Lipe & Dalton’s Lam Research LRCX Stock Holding History

Lipe & Dalton’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	+300	New	+$91.1K	0.06%	77

Other funds holding LRCX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Lipe & Dalton's LRCX Position: Q2 2026 in Review

Lipe & Dalton opened a new position in Lam Research (LRCX) in Q2 2026: 300 shares worth $130K. The stake represents 0.06% of the portfolio and ranks #77 among its holdings.

1,427 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Lipe & Dalton held 300 shares of Lam Research worth $130K as of Q2 2026.
Lam Research was a new Lipe & Dalton position in Q2 2026.
Lam Research made up 0.06% of Lipe & Dalton's portfolio in Q2 2026, its #77 holding.
1,427 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.